Evaluation of efficacy of GCSF in reducing neutropenia among carcinoma patients undergoing anti-cancer chemotherapy. A prospective cohort study

Evaluation of efficacy of GCSF in reducing neutropenia among carcinoma patients undergoing anti-cancer chemotherapy. A prospective cohort study

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Maria Kakar, Sami Ullah, Amjad Khan, Shabnam Nazir
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695004/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of efficacy of GCSF in reducing neutropenia among carcinoma patients undergoing anti-cancer chemotherapy. A prospective cohort study.
by: Maria Kakar, et al.
Published: (2025-01-01)

Am80‐GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia‐associated infection and mortality
by: Lin Li, et al.
Published: (2016-10-01)

Oral ulcers in hematological malignancy patients undergoing chemotherapy: is it chemotherapy or neutropenia?: a case report and review of the literature
by: Fatima AlZahraa Al Beesh, et al.
Published: (2025-03-01)

The combination of fatigue with the serum GCSF improves the performance of serological screening for frailty
by: Yu Jiaming, et al.
Published: (2025-02-01)

Lipegfilgrastim in patients with chemotherapy-induced neutropenia
by: G. D. Petrova, et al.
Published: (2015-12-01)

Chemotherapy limiting neutropenia. Is prevention required?
by: I. B. Kononenko, et al.
Published: (2022-01-01)

Chemotherapy-induced neutropenia and its determinants in patients with solid malignancies: A prospective observational study
by: Whitney Joseph J, et al.
Published: (2025-07-01)

Oral manifestations of Chemotherapy-Induced Neutropenia in adult patients
by: Saya Salam Salih, et al.
Published: (2025-06-01)

Prevention of neutropenia during chemotherapy by prolonged myelostimulatory preparations
by: V. V. Ptushkin, et al.
Published: (2015-06-01)

Assessment of chemotherapy-induced febrile neutropenia in cancer patients
by: Malona Lilly Philip, et al.
Published: (2019-01-01)

Role of Biochemical Inflammatory Markers in Patients with Chemotherapy-Induced Neutropenia
by: YuN Dubinina, et al.
Published: (2019-09-01)

Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
by: Advani S, et al.
Published: (2010-01-01)

Prevention of neutropenia as an important factor in successful chemotherapy for head and neck cancer
by: L. G. Babicheva, et al.
Published: (2021-11-01)

Role of gut microbiota in predicting chemotherapy-induced neutropenia duration in leukemia patients
by: Yezi Huang, et al.
Published: (2025-03-01)

Comparison of CISNE and MASCC Score in Predicting Complications on Post Chemotherapy Febrile Neutropenia
by: Sharifah Shakinah, et al.
Published: (2024-07-01)

Comparison of CISNE and MASCC Score in Predicting Complications on Post Chemotherapy Febrile Neutropenia
by: Sharifah Shakinah, et al.
Published: (2024-10-01)

Molecular Adjuvant Potential of <i>GCSF</i> and <i>MCSF</i> in Starry Flounder Challenged with <i>Streptococcus parauberis</i>
by: Min-Young Sohn, et al.
Published: (2025-06-01)

Incidence of Chemotherapy-Induced Fever and Neutropenia in Different Chemotherapy Regimens in Hospitalized Patients with Non-Metastatic Breast Cancer
by: Mehran Sharifi, et al.
Published: (2024-12-01)

Change of Coagulation Status in Solid Cancer Patients Undergoing Chemotherapy in Indonesia: A Prospective Cohort Study
by: Noorwati Sutandyo, et al.
Published: (2020-03-01)

A Case of Autoimmune Neutropenia in a Patient Undergoing Breast Cancer Surgery
by: Mio Adachi, et al.
Published: (2024-01-01)

Staged CBI for Reducing Anxiety and Depression in Lung Cancer Patients Undergoing Chemotherapy: A Retrospective Cohort Analysis
by: Chen L, et al.
Published: (2025-06-01)

Colistine pharmacokinetics and Colistimethate sodium daily dose calculation in children with chemotherapy induced neutropenia
by: V. I. Zakharevich, et al.
Published: (2014-09-01)

The Role of Initial Neutropenia and Neutrophil Dynamics in Personalizing Chemotherapy for Platinum-Resistant Ovarian Cancer
by: Radu-Dumitru Dragomir, et al.
Published: (2025-03-01)

Secondary Neutropenias
by: Alister C. Ward
Published: (2025-02-01)

Telpegfilgrastim for chemotherapy-induced neutropenia in breast cancer: A multicenter, randomized, phase 3 study
by: Yuankai Shi, et al.
Published: (2025-02-01)

CHEMOTHERAPY-INDUCED NEUTROPENIA IN HIV POSITIVE PATIENTS WITH LYMPHOMA: COMPARISON OF PEGFILGRASTIM WITH DAILY FILGRASTIM ADMINISTRATION.
by: Luciana Teofili, et al.
Published: (2012-01-01)

Value of incorporating newly identified risk factors into risk prediction for chemotherapy‐induced febrile neutropenia
by: Yanli Li, et al.
Published: (2018-08-01)

Ceftazidime-avibactam for the treatment of febrile neutropenia in HSCT recipients and acute leukemia patients post induction chemotherapy
by: Jim Abi Frem, et al.
Published: (2024-12-01)

Olanzapine-induced neutropenia
by: Kirti Malhotra, et al.
Published: (2015-06-01)

Study of PEG-rhG-CSF for the prevention of neutropenia in concurrent chemoradiotherapy for nasopharyngeal carcinoma.
by: Lu Yang, et al.
Published: (2025-01-01)

Drug-Induced Neutropenia and Agranulocytosis
by: O. D. Ostroumova, et al.
Published: (2020-09-01)

Mortality Related to Coagulase-Negative Staphylococcal Bacteremia in Febrile Neutropenia: A Cohort Study
by: Regis G Rosa, et al.
Published: (2014-01-01)

Level of Knowledge and Incidence of Emergency Oncology: Febrile Neutropenia in Hematologic Cancer Patients Post Chemotherapy: A Descriptive Study
by: Agus Suryaman
Published: (2024-12-01)

diagnostic utility of procalcitonin in children with infectious complications during chemotherapy-induced neutropenia: single center experience, literature review
by: Yu. V. Dinikina, et al.
Published: (2020-04-01)

Comparison of clinical outcomes of treatment with cefepime monotherapy vs. amikacin-ceftriaxone combination in children with chemotherapy-induced fever and neutropenia
by: Zahra Ghelichkhan, et al.
Published: (2025-04-01)

Renal impairment as a risk factor for chemotherapy induced neutropenia in the treatment of trifluridine/thymidine phosphorylase inhibitor plus bevacizumab
by: Masatsune Shibutani, et al.
Published: (2025-01-01)

Inulin Supplementation Reduces Systolic Blood Pressure in Women with Breast Cancer Undergoing Neoadjuvant Chemotherapy
by: Yizel Becerril-Alarcón, et al.
Published: (2019-01-01)

Response of Capecitabine and Oxaliplatin Chemotherapy in Metastatic Colorectal Carcinoma
by: Asma Abdul Rashid, et al.
Published: (2025-01-01)

Telpegfilgrastim for chemotherapy-induced neutropenia in patients with non-small cell lung cancer: a multicentre, randomized, phase 3 study
by: Yuankai Shi, et al.
Published: (2025-03-01)

Thrombin generation in children with febrile neutropenia
by: Ayça Koca Yozgat, et al.
Published: (2021-04-01)